Product news

Share this article:
Shire's Vyvanse, an attention deficit and hyperactivity disorder drug, has received approval for adults. Vyvanse is now available in three additional dosage strengths.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.